New stroke drug shows promise in early trial
NCT ID NCT06202378
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new drug called SHPL-49 in 270 people who had an acute ischemic stroke. Participants received either the drug or a placebo as an IV infusion twice daily for 7 days. The goal was to see if the drug helps improve recovery and is safe to use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SHPL-49 injection
What this could lead to
If successful, this could point toward a new treatment to improve recovery after a stroke.
What could go wrong
This is a Phase 2 trial, so results are still early. The treatment may not prove effective or safe in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tiantan Hosptial，Capital Medical University
Beijing, Beijing Municipality, 100070, China
-
Beipiao Central Hospital
Beipiao, Liaoning, 122199, China
-
General Hospital of Pingmei Shenma Group
Pingdingshan, Henan, 467099, China
-
Hengshui People's Hospital
Hengshui, Hebei, 053099, China
-
Keshiketeng Banner Traditional Chinese Medicine and Mongolian Medicine Hospital
Chifeng, Inner Mongolia, 025350, China
-
Linfen Central Hospital
Linfen, Shanxi, 041000, China
-
Linfen People's Hospital
Linfen, Shanxi, 041000, China
-
Linyi People's Hospital
Linyi, Shandong, 276100, China
-
Nanshi Hospital of Nanyang
Nanyang, Henan, 473010, China
-
Shenyang Medical College Affiliated Central Hospital
Shenyang, Liaoning, 110024, China
-
Sinopharm Tongmei General Hospital
Datong, Shanxi, 037001, China
-
Tangshan Workers' Hospital
Tangshan, Hebei, 063099, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
-
The First People's Hospital of Shenyang
Shenyang, Liaoning, 110041, China
-
The First People's Hospital of Tancheng
Linyi, Shandong, 276100, China
-
Yuebei People's Hospital
Shaoguan, Guangdong, 512026, China